Science Explorer Back to mapMap
Discussion
Company · Cambridge · United Kingdom

Recombinant Antibody Technology (United Kingdom)

ratltd.netROR OpenAlex
Research works
101
▼ 52% vs 2018-21
Citations
6.6k
65.9 per fractional work
Top-10% rate
15.3%
all institutions 10.0%
Open access
46%
world 40%
International
38%
world 18%
Recombinant Antibody Technology (United Kingdom)

Not ranked overall: Recombinant Antibody Technology (United Kingdom) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Recombinant Antibody Technology (United Kingdom) work in?

In all years, 47% of research at Recombinant Antibody Technology (United Kingdom) is in Life Sciences, 40% in Health Sciences. Its largest fields are Medicine (39%), Biochemistry, Genetics and Molecular Biology (36%), Immunology and Microbiology (8%). It does 2.8× the world's share of Life Sciences.

Life Sciences: 48 fractional works · 47.2% of its workBiochemistry, Genetics and Molecular Biology: 36 fractional works · 35.9% of its workMolecular Biology: 30 fractional works · 29.6% of its workGenetics: 3 fractional works · 2.6% of its workBiotechnology: 2 fractional works · 1.7% of its workCell Biology: 1 fractional works · 1.1% of its workCancer Research: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 8 fractional works · 8.0% of its workImmunology: 8 fractional works · 7.6% of its workMicrobiology: 0 fractional works · 0.3% of its workNeuroscience: 2 fractional works · 2.2% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.4% of its workNeurology: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.7% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workHealth Sciences: 41 fractional works · 40.5% of its workMedicine: 39 fractional works · 38.8% of its workRadiology, Nuclear Medicine and Imaging: 20 fractional works · 19.5% of its workOncology: 3 fractional works · 3.4% of its workPhysiology: 3 fractional works · 2.5% of its workHematology: 2 fractional works · 2.3% of its workPulmonary and Respiratory Medicine: 2 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.3% of its workSurgery: 1 fractional works · 1.1% of its workGenetics: 1 fractional works · 1.1% of its workRheumatology: 1 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.8% of its workImmunology and Allergy: 1 fractional works · 0.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.7% of its workEpidemiology: 1 fractional works · 0.6% of its workInfectious Diseases: 1 fractional works · 0.6% of its workNephrology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 1.0% of its workHealth Professions: 1 fractional works · 1.2% of its workEmergency Medical Services: 1 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 1 fractional works · 0.5% of its workNutrition and Dietetics: 1 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.0% of its workPhysical Sciences: 12 fractional works · 11.5% of its workEngineering: 5 fractional works · 5.2% of its workBiomedical Engineering: 2 fractional works · 1.7% of its workMechanical Engineering: 2 fractional works · 1.5% of its workComputational Mechanics: 1 fractional works · 1.2% of its workMedia Technology: 0 fractional works · 0.3% of its workElectrical and Electronic Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workEnvironmental Science: 2 fractional works · 2.1% of its workEcology: 2 fractional works · 2.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 1.1% of its workInformation Systems: 0 fractional works · 0.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workChemistry: 1 fractional works · 1.0% of its workOrganic Chemistry: 0 fractional works · 0.4% of its workAnalytical Chemistry: 0 fractional works · 0.3% of its workSpectroscopy: 0 fractional works · 0.3% of its workMaterials Science: 1 fractional works · 0.8% of its workBiomaterials: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 1 fractional works · 0.7% of its workNuclear and High Energy Physics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.3% of its workGeophysics: 0 fractional works · 0.3% of its workEnergy: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 0.9% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.2% of its workALL ITS WORKRecombinantAntibody…101fractional works, all years
Life Sciences47%Physical Sciences11%Health Sciences40%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 23 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3635.9%
    2. Immunology and Microbiology88.0%
    3. Neuroscience22.2%
    4. Agricultural and Biological Sciences10.7%
    5. Pharmacology, Toxicology and Pharmaceutics10.5%
    1. Medicine3938.8%
    2. Health Professions11.2%
    3. Nursing10.5%
    4. Veterinary00.0%
    1. Engineering55.2%
    2. Environmental Science22.1%
    3. Computer Science11.1%
    4. Chemistry11.0%
    5. Materials Science10.8%
    6. Physics and Astronomy10.7%
    7. Earth and Planetary Sciences00.3%
    8. Energy00.1%
    9. Mathematics00.1%
    1. Business, Management and Accounting00.3%
    2. Social Sciences00.2%
    3. Decision Sciences00.2%
    4. Psychology00.2%
    5. Economics, Econometrics and Finance00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.27× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 5.17× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 1.70× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.31× its world share, 0 worksChemistryComputer Science: 0.67× its world share, 0 worksComputer ScienceEngineering: 0.24× its world share, 0 worksEngineeringEnvironmental Science: 0.24× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.34× its world share, 0 worksMaterials ScienceMathematics: 0.82× its world share, 0 worksMathematicsPhysics and Astronomy: 0.72× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.91× its world share, 0 worksHealth ProfessionsMedicine: 1.89× its world share, 2 worksMedicineVeterinary: 5.04× its world share, 0 worksVeterinaryDecision Sciences: 2.48× its world share, 0 worksDecision SciencesSocial Sciences: 0.13× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.3×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology6.27×2 works
  2. Immunology and Microbiology5.17×0 works
  3. Veterinary5.04×0 works
  4. Decision Sciences2.48×0 works
  5. Chemistry2.31×0 works
  6. Medicine1.89×2 works
  7. Pharmacology, Toxicology and Pharmaceutics1.70×0 works
  8. Health Professions0.91×0 works
  9. Mathematics0.82×0 works
  10. Physics and Astronomy0.72×0 works
  11. Computer Science0.67×0 works
  12. Materials Science0.34×0 works
  13. Engineering0.24×0 works
  14. Environmental Science0.24×0 works
  15. Social Sciences0.13×0 works

Who are the top researchers at Recombinant Antibody Technology (United Kingdom)?

Ranked on the quality score, David J. Chiswell lead among researchers whose main affiliation is Recombinant Antibody Technology (United Kingdom).

  1. 1 David J. Chiswell United Kingdom · #1,496,640 worldwide 4.3k citations · 24 works
All ranked researchers at Recombinant Antibody Technology (United Kingdom)

What are the most cited papers from Recombinant Antibody Technology (United Kingdom)?

The most cited paper from Recombinant Antibody Technology (United Kingdom) is "Phage antibodies: filamentous phage displaying antibody variable domains" (John McCafferty, Andrew D. Griffiths, Greg P. Winter et al., 1990), with 2,430 citations. Next come "By-passing immunization" (1,609) and "Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library" (1,038).

Most cited papers
#PaperReleasedCitations
1 Phage antibodies: filamentous phage displaying antibody variable domains John McCafferty, Andrew D. Griffiths, Greg P. Winter et al. · Nature Dec 1990 2,430
2 By-passing immunization James D. Marks, Hennie R. Hoogenboom, Timothy P. Bonnert et al. · Journal of Molecular Biology Dec 1991 1,609
3 Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library Tristan J. Vaughan, Andrew J Williams, Kevin T. Pritchard et al. · Nature Biotechnology Mar 1996 1,038
4 Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains Hennie R. Hoogenboom, Andrew D. Griffiths, Kevin Scot Johnson et al. · Nucleic Acids Research Open access 1991 1,023
5 Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy Qian Gong, Qinglin Ou, Shiming Ye et al. · The Journal of Immunology 2005 546
All 60 most cited papers, with filters and sorting

Which keywords describe research at Recombinant Antibody Technology (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cancer, Biopharmaceuticals and Recombinant Proteins.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation29▲ 130×3 topics
  2. Monoclonal Antibodies26▲ 179×3 topics
  3. Therapeutic Antibodies25▲ 195×2 topics
  4. Antibody Engineering19▲ 190×1 topic
  5. Fc Receptors19▲ 190×1 topic
  6. Cancer10▲ 6.8×13 topics
  7. Biopharmaceuticals8▲ 122×3 topics
  8. Recombinant Proteins8▲ 144×2 topics
  9. Glycans7▲ 88×1 topic
  10. Immune System7▲ 22×1 topic
  11. Immunogenicity7▲ 132×2 topics
  12. Protein Aggregation6▲ 79×2 topics
  13. Chromatography6▲ 211×1 topic
  14. Stability6▲ 32×1 topic
  15. Inflammation4▲ 1.83×23 topics
  16. Autoimmunity3▲ 16×3 topics
  17. Biopharmaceutical Production3▲ 40×2 topics
  18. Monoclonal Antibody3▲ 46×2 topics
  19. TGF-ß3▲ 16×3 topics
  20. Mammalian Cells3▲ 68×1 topic
  21. Recombinant Protein3▲ 68×1 topic
  22. CD4+CD25+3▲ 35×1 topic
  23. Foxp33▲ 35×1 topic
  24. Cell Signaling2▲ 7.2×6 topics
  25. Drug Discovery2▲ 6.0×4 topics
  26. High-Throughput Analysis2▲ 52×1 topic
  27. Protein Microarrays2▲ 120×1 topic
  28. Cancer Immunotherapy2▲ 16×2 topics
  29. Targeted Therapy2▲ 9.7×3 topics
  30. Therapy2▲ 8.9×3 topics
  31. Signal Transduction2▲ 7.3×2 topics
  32. Microbiome2▲ 12×2 topics
  33. Tumor Regression2▲ 20×2 topics
  34. Virus2▲ 14×2 topics
  35. Bacteriophage2▲ 24×1 topic
  36. CAR T Cells2▲ 37×1 topic
  37. Chimeric Antigen Receptor2▲ 37×1 topic
  38. Ecology2▲ 7.7×1 topic
  39. Plant Molecular Farming2▲ 64×1 topic
  40. Vaccine Antigens2▲ 64×1 topic

Which research topics does Recombinant Antibody Technology (United Kingdom) publish most on?

By volume in 2022-now: Cancer Genomics and Diagnostics, Molecular Biology Techniques and Applications, Monoclonal and Polyclonal Antibodies Research and Immunotherapy and Immune Responses.

Cancer Genomics and Diagnostics: 0 fractional worksMolecular Biology Techniques and Applications: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksImmunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional worksSinusitis and nasal conditions: 0 fractional worksPharmaceutical Practices and Patient Outcomes: 0 fractional worksRenal cell carcinoma tre…0Renal cell carcinoma treatment: 0 fractional worksData Visualization and Analytics: 0 fractional worksHead and Neck Surgical Oncology: 0 fractional worksMeta-analysis and system…0Meta-analysis and systematic reviews: 0 fractional works
Cancer ResearchMolecular BiologyRadiology, Nuclear Medicine and ImagingImmunology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 0 works
  2. 2 Molecular Biology Techniques and Applications Molecular Biology 0 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Immunotherapy and Immune Responses Immunology 0 works
  5. 5 Sinusitis and nasal conditions Otorhinolaryngology 0 works
  6. 6 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 0 works
  7. 7 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  8. 8 Data Visualization and Analytics Computer Vision and Pattern Recognition 0 works
  9. 9 Head and Neck Surgical Oncology Surgery 0 works
  10. 10 Meta-analysis and systematic reviews Statistics, Probability and Uncertainty 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.9%not open54.1%

World: 40% of research is openly available.

with international co-authors37.6%domestic only62.4%

World: 18% is written across borders.

How has Recombinant Antibody Technology (United Kingdom)'s research output changed?

Output in 2022-2025 was 52% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Recombinant Antibody Technology (United Kingdom) as a percentage of every work published that year, 0.000023% in 2024.

still counting0.00020%0.00040%0.00060%Recombinant Antibody Technology (United Kingdom)0.000038% in 20251990200020102020

Fractional works of Recombinant Antibody Technology (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Recombinant Antibody Technology (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.